Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics, meets with representatives of Tongshu Gene during working sessions in China focused on VitaGuard™ technology transfer, implementation planning and international commercialization.
Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics, meets with representatives of Tongshu Gene during working sessions in China focused on VitaGuard™ technology transfer, implementation planning and international commercialization. The visit included Tongshu Gene facilities in Shanghai and Changzhou.
Format
JPEG
Source
BioNexus Gene Lab Corp.